Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
11/2002
11/06/2002EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002EP0800528B1 Peptide and peptide analog protease inhibitors
11/06/2002CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/06/2002CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002CN1377881A Intermediate for preparing cascade polymeric ligand and contrast medium
11/05/2002WO2001085673A1 Phenyl-substituted 2-enamino-keto nitriles
11/05/2002US6476231 Cyclization using acyl halogenide; chemical intermediate
11/05/2002US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476056 Antiinflammatory agents, psychological disorders
11/05/2002CA2408209A1 Phenyl-substituted 2-enamino-keto nitriles
10/2002
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002WO2002085303A2 Substituted tetracycline compounds for the treatment of malaria
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002WO2001058855A9 Use of androgen receptor suppressors
10/31/2002US20020160987 Novel 4-dedimethylaminotetracycline derivatives
10/31/2002US20020159961 Gelling agent for oil
10/30/2002EP1252209A1 Compositions comprising antioxidant amines based on n-(4-anilinophenyl) amides
10/30/2002EP1252134A1 Method for producing acetoacetylated aromatic amines
10/30/2002EP1004573B1 Aryloxyaniline derivatives
10/30/2002EP0968423A4 Convergent synthesis of combinatorial library
10/30/2002EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002CN1377298A Method for activating passivated iron
10/29/2002US6472415 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
10/29/2002US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002US6472349 Pyridine-2,3-dicarboxylic acid diamides
10/24/2002WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002WO2002083623A1 Process for the production of high purity iohexol
10/24/2002WO2002083120A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002US20020156237 Novel amide-based cationic lipids
10/24/2002US20020155993 Especially those derived from two alpha-amino acids independently selected from the group consisting of glutamic acid, aspartic acid, tyrosine, phenylalanine, and optical isomers thereof.
10/24/2002US20020155065 Dissolving diethylenetriaminepentaacetic- bisanhydride of formula in dimethyl sulfoxide or in dimethylformamide or in a mixture; adding solubilizer, an auxiliary base and a monoamine or diamine, heating
10/24/2002CA2763637A1 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/23/2002CN1376143A Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
10/23/2002CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/22/2002US6469208 Crystalline iohexol containing residual solvents (isopropyl alcohol) above 100 ppm is suspended in a combination of ethanol and water, heated, filtered and then dried
10/22/2002US6469199 Secondary aspartic acid amide esters
10/22/2002US6469047 Tyrosine derivatives
10/22/2002US6468502 Paramagnetic macromolecules with higher proton relaxivity; lower dosage and increased signal intensity; detecting vascular diseases; differentiating tissue blood supply levels; distinguishing myocardial infarction from ischemia
10/22/2002US6468487 Nitration or carboxylation catalysts
10/17/2002WO2002008247A3 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide
10/17/2002WO2001096283A9 Hiv integrase inhibitors
10/17/2002US20020151596 Novel process to prepare 2-aminoindan derivatives
10/17/2002US20020151534 Antithrombotic compounds
10/17/2002US20020151529 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
10/17/2002US20020151070 Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy
10/17/2002DE10114970A1 New 1,2-diamino-4-azolyl-, -4-furyl-, -4-thienyl-, -4-phenyl- and -4-azinyl-benzene compounds and known analogues are used in oxidative colorants for keratin fibers, especially human hair
10/16/2002EP0920434B1 Bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
10/16/2002CN1374076A hair cosmetics, aminocarboxylic acid amide and its producing process
10/15/2002US6465694 Method for preparation of polyethylene glycol aldehyde derivatives
10/15/2002US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002US6465455 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/15/2002CA2112690C Amino acid derivative
10/10/2002WO2003084997A1 Probes, systems and methods for drug discovery
10/10/2002WO2002079145A1 BENZAMIDE INHIBITORS OF FACTOR Xa
10/10/2002WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002WO2002036546A3 Alkynyl amides and their therapeutic applications
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002US20020147204 Amide derivative
10/10/2002US20020147191 Antiinflammatory agents, psychological disorders
10/10/2002US20020147182 13-substituted methacycline compounds
10/10/2002DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant
10/10/2002CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002CA2442654A1 Probes, systems, and methods for drug discovery
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/09/2002CN1092182C Process for preparation of contrast agent
10/08/2002US6462179 Conjugation to peptides, proteins, hormones, polysaccharides, nucleic acids, haptens, drugs, ligands, toxins, halophors, and other macromolecules
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002US6462034 Multibinding compounds containing a symetrical diaminotetra-etherdodecane ring with two secondary amide and additional substituents; voltage gated sodium channel modulators; long duration
10/08/2002US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide
10/03/2002WO2002076968A1 Malonates as inhibitors of the ice/ced-6 family of cysteine proteases
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002030880A3 N-substituted amino acid derivatives (factor xa inhibitors)
10/03/2002US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
10/03/2002US20020142998 For prophylaxis and therapy
10/03/2002US20020142967 Thrombin inhibitors
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/02/2002EP1244624A1 Anthracene derivatives as anti-cancer agents
10/02/2002EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
10/02/2002EP0915832B1 Boronic compound complexing reagents and highly stable complexes
10/02/2002EP0717750B1 Double-stranded peptide nucleic acids
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002DE10112924A1 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate 1-butanoic acid derivatives, pharmaceutical compositions containing such derivatives and uses of such derivatives
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458781 Blockers calcium channel antagonists for strokes, brain disorders
10/01/2002US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
10/01/2002US6458381 Lipids and their use, for example, in liposomes
10/01/2002US6458337 Diagnostic imaging contrast agent with improved in serum relaxivity
09/2002
09/26/2002WO2002074732A2 Tryptase-inhibitors
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 162